Morinaga Milk on three new growth engines for probiotic business in China
Morinaga Milk has identified three new growth engines to stand out in the highly competitive probiotic market in China. These are namely infant nutrition, weight management, and cognitive support.
Currently, infant nutrition is the company’s main business in China, with Bifidobacterium longum subsp. longum BB536 being a popular probiotic strain used in infant formulas.
There are now further opportunities for its other proprietary probiotic ingredients. One of these is B. longum subsp. infantis M-63, which was approved by the Chinese authorities as a new ingredient for use in infant and children foods (under the age of three) last July.
Monteloeder seeks to address ‘chronic sleep debt’, growing teenage well-being category
Monteloeder is eyeing opportunities in the emerging teenage well-being category, particularly in Asian countries such as China, Japan, and South Korea, where sleep deprivation and academic stress are rife.
The SuanNutra-owned company recently announced the results from a study that showed its RelaxPLX, a natural lemon verbena extract, could help support relaxation and sleep quality in teenagers experiencing occasional stress and restlessness.
Rohto joins pill-and-shot supplement trend, outlines 10-year R&D pipeline
Rohto Pharmaceutical’s latest supplement launch is in the pill-and-shot format that has been popularised in South Korea in the past two years.
The beauty-from-within supplement, launched under the brand MOCOLA, contains a 20ml collagen drink and a tablet containing vitamin C, B6, D.
The company also announced its 10-year R&D pipeline, where it would be working on new products made from botanicals, as well as those for gut health.
Japanese start-up debuts ageing-support supplement made from parsley-derived exosomes
Biotech firm TIME TRAVELER has launched a supplement targeting the ageing generation and formulated with parsley-derived exosomes, which it claims to be a first in the market.
The product contains an ingredient called T-GREEN EXOSOME, which was developed using patented technology exclusively licensed from the University of Tokyo.
This technology is said to allow for high-precision extraction, ensuring a stable blend of high-purity plant-derived exosomes.
Sake by-product shown to relieve constipation in pilot study
The consumption of the by-product of sake has been shown to relieve constipation in a pilot study.
The study was conducted by researchers from the Kanazawa University, University of Fukui, and KAGAMI INC.
Writing in PLoS One, the researchers said that sake lees has been shown to significantly improve secondary end-points of constipation and the gut microbiome.
